 |
Anaritide acetate |
|---|---|
| Trade Name | Auriculin |
| Orphan Indication | Improvement of early renal allograft function following renal transplantation |
| USA Market Approval | USA |
| USA Designation Date | 1992-04-10 00:00:00 |
| Sponsor | Scios, Inc.;2450 Bayshore Parkway;Mountain View, California, 94043 |
